[GCB] QoQ Cumulative Quarter Result on 30-Jun-2021 [#2]

Stock
[GCB] GUAN CHONG BHD
Announcement Date
23-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- 107.35%
YoY- -45.57%
Quarter Report
Latest QR
Upcoming QR
GCB's Result
GCB's Financial Summary
View:
Show?
Cumulative Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 990,527 3,922,792 2,834,451 1,836,347 960,121 3,684,972 2,661,746 -48.29%
PBT 64,638 197,921 126,533 84,845 40,946 269,220 213,454 -54.93%
Tax -11,369 -41,942 -21,793 -14,560 -7,050 -46,028 -37,534 -54.93%
NP 53,269 155,979 104,740 70,285 33,896 223,192 175,920 -54.94%
-
NP to SH 53,269 155,979 104,740 70,285 33,896 223,192 175,920 -54.94%
-
Tax Rate 17.59% 21.19% 17.22% 17.16% 17.22% 17.10% 17.58% -
Total Cost 937,258 3,766,813 2,729,711 1,766,062 926,225 3,461,780 2,485,826 -47.84%
-
Net Worth 1,402,698 1,343,474 1,299,952 1,248,775 1,222,410 1,189,658 1,161,709 13.40%
Dividend
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Div 15,825 41,671 20,737 10,351 10,343 35,713 25,351 -26.98%
Div Payout % 29.71% 26.72% 19.80% 14.73% 30.52% 16.00% 14.41% -
Equity
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Net Worth 1,402,698 1,343,474 1,299,952 1,248,775 1,222,410 1,189,658 1,161,709 13.40%
NOSH 1,057,132 1,054,806 1,051,491 1,035,125 1,035,161 1,034,307 1,032,116 1.61%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 5.38% 3.98% 3.70% 3.83% 3.53% 6.06% 6.61% -
ROE 3.80% 11.61% 8.06% 5.63% 2.77% 18.76% 15.14% -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 93.88 376.55 273.36 177.40 92.82 361.14 262.48 -49.64%
EPS 5.05 14.97 10.10 6.79 3.28 21.87 17.35 -56.11%
DPS 1.50 4.00 2.00 1.00 1.00 3.50 2.50 -28.88%
NAPS 1.3295 1.2896 1.2537 1.2064 1.1818 1.1659 1.1456 10.44%
Adjusted Per Share Value based on latest NOSH - 1,036,723
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 84.31 333.88 241.25 156.30 81.72 313.64 226.55 -48.29%
EPS 4.53 13.28 8.91 5.98 2.88 19.00 14.97 -54.95%
DPS 1.35 3.55 1.77 0.88 0.88 3.04 2.16 -26.92%
NAPS 1.1939 1.1435 1.1064 1.0629 1.0404 1.0125 0.9888 13.40%
Price Multiplier on Financial Quarter End Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 -
Price 2.65 2.80 2.96 2.73 3.14 2.67 3.30 -
P/RPS 2.82 0.74 1.08 1.54 3.38 0.74 1.26 71.18%
P/EPS 52.49 18.70 29.30 40.21 95.82 12.21 19.02 96.86%
EY 1.91 5.35 3.41 2.49 1.04 8.19 5.26 -49.13%
DY 0.57 1.43 0.68 0.37 0.32 1.31 0.76 -17.46%
P/NAPS 1.99 2.17 2.36 2.26 2.66 2.29 2.88 -21.85%
Price Multiplier on Announcement Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 30/05/22 21/02/22 22/11/21 23/08/21 27/05/21 26/02/21 23/11/20 -
Price 2.23 3.05 2.76 2.83 2.80 2.66 3.11 -
P/RPS 2.38 0.81 1.01 1.60 3.02 0.74 1.18 59.70%
P/EPS 44.17 20.37 27.32 41.68 85.44 12.16 17.93 82.50%
EY 2.26 4.91 3.66 2.40 1.17 8.22 5.58 -45.28%
DY 0.67 1.31 0.72 0.35 0.36 1.32 0.80 -11.15%
P/NAPS 1.68 2.37 2.20 2.35 2.37 2.28 2.71 -27.31%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment